Sling offers lasting benefit for stress urinary incontinence

October 22, 2012
Sling offers lasting benefit for stress urinary incontinence
Stress urinary incontinence treatment with a distal urethral polypropylene sling procedure is associated with excellent long-term efficacy and durability, according to research published in the November issue of The Journal of Urology.

(HealthDay)—Stress urinary incontinence treatment with a distal urethral polypropylene sling procedure is associated with excellent long-term efficacy and durability, according to research published in the November issue of The Journal of Urology.

Lisa Rogo-Gupta, M.D., of the Geffen School of Medicine at the University of California in Los Angeles, and colleagues conducted a prospective study involving 69 consecutive patients who underwent a distal urethral polypropylene sling procedure for the treatment of . Long-term follow-up data at a minimum of 11 years were available for 30 patients (mean age at follow-up, 73 years).

Of the patients lost to follow-up, 10 were deceased and five were cognitively impaired. At follow-up, the researchers found that 48 percent of patients reported no symptoms of stress urinary incontinence and 63 percent reported not being bothered by stress urinary incontinence. Overall, symptoms improved an average of 64 percent at 11 years, compared with 81 percent at five years. Based on symptom scores, 82 percent of patients were rated as successes, while 80 percent were rated as successes based on bother scores.

"The distal urethral polypropylene sling procedure has excellent long-term durability in the treatment of stress urinary incontinence, in addition to low morbidity and low cost as previously described," the authors write. "When choosing an anti-incontinence procedure, durability should be considered in light of patient age given that the theoretical advantages of long-term durability are limited by and mortality."

One author disclosed to Astellas and .

More information: Abstract
Full Text

Related Stories

Colpocleisis deemed safe for advanced pelvic organ prolapse

August 31, 2012

(HealthDay)—Colpocleisis is a safe and effective treatment for advanced pelvic organ prolapse; however, urinary frequency and urgency often persist after the procedure, according to research published in the September issue ...

Recommended for you

Experimental MERS vaccine shows promise in animal studies

July 28, 2015

A two-step regimen of experimental vaccines against Middle East respiratory syndrome (MERS) prompted immune responses in mice and rhesus macaques, report National Institutes of Health scientists who designed the vaccines. ...

Can social isolation fuel epidemics?

July 21, 2015

Conventional wisdom has it that the more people stay within their own social groups and avoid others, the less likely it is small disease outbreaks turn into full-blown epidemics. But the conventional wisdom is wrong, according ...

Lack of knowledge on animal disease leaves humans at risk

July 20, 2015

Researchers from the University of Sydney have painted the most detailed picture to date of major infectious diseases shared between wildlife and livestock, and found a huge gap in knowledge about diseases which could spread ...

IBD genetically similar in Europeans and non-Europeans

July 20, 2015

The first genetic study of inflammatory bowel disease (IBD) to include individuals from diverse populations has shown that the regions of the genome underlying the disease are consistent around the world. This study, conducted ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.